HLA class I gene products are immunocytochemically detectable in the skeletal muscle of many patients with inflammatory conditions. We report three cases of juvenile dermatomyositis with minimal histologic abnormalities and no inflammation in the muscle biopsies. All three showed strong expression of HLA class I antigens on muscle fibers. Analysis of HLA class I expression is thus a useful marker for the diagnosis of inflammatory muscle disease, even in the absence of histologic changes. (J Child Neurol 1997;12:60-63).
Get full access to this article
View all access options for this article.
References
1.
Engel A., Arahata K.: Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol1984;16:193-208.
2.
Hohlfeld R., Engel A.: The role of gamma-delta T lymphocytes in inflammatory muscle disease . Chem Immunol1992;53:75-85.
3.
Kissel JT, Mendell JR, Rammohan KW: Microvascular deposition of complement membrane attack complex in dermatomyositis . N Engl J Med1986;314:329-334.
4.
Sewry CA, Dubowitz V., Abraha A., et al: Immunocytochemical localisation of complement components C8 and C9 in human diseased muscle. The role of complement in muscle fibre damage . J Neurol Sci1987;81:141-153.
5.
Kissel JT, Halterman RK, Rammohan KW, Mendell JR: The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol1991;48:26-30.
6.
Roitt IM, Brostoff J , Male D (eds): Immunology, 3rd ed. St Louis , Mosby, 1993.
7.
Appleyard ST , Dunn MJ, Dubowitz V., Rose ML: Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet1985 ;i:361-363.
8.
Isenberg DA, Rowe D., Shearer M., et al: Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol1986 ;63:450-458.
9.
Karpati G., Pouliot Y., Carpenter S.: Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol1988 ;23:64-72.
10.
Emslie-Smith AM, Arahata K., Engel A.: Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol1989 ;20:224-231.
11.
McDouall RM , Dunn MJ, Dubowitz V.: Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci1988 ;89:213-226.
12.
Sewry C., Dubowitz V.: Histochemical and immunocytochemical studies in neuromuscular diseases , in Walton J, Karpati G, Hilton-Jones D (eds): Disorders of Voluntary Muscle, 6th ed. Edinburgh, Churchill-Livingstone, 1994, pp 261-318.
13.
Dubowitz V. : Muscle Disorders in Childhood, 2nd ed. London, WB Saunders, 1995.
14.
Dalakas MC: Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med1991;325:1487-1498.
15.
Bohan A., Peter JB: Polymyositis and dermatomyositis. N Engl J Med1975;292:403-407.
16.
Dubowitz V. : Muscle Biopsy. A Practical Approach, 2nd ed. London, Baillière-Tindall , 1985.
17.
Zuk JA, Fletcher A.: Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate . J Clin Pathol1988;41:410-414.
18.
Allbrook D. : Skeletal muscle regeneration. Muscle Nerve1981;4:234-245.
19.
Wilson LA, Dux L., Cooper BJ, et al: Experimental regeneration in canine muscular dystrophy-2. Expression of myosin heavy chain isoforms. Neuromusc Disord1994;4:25-37.
